newest HIV drugs, Emtriva and Reyataz

August 2003

You might get questions about the newest HIV drugs, Emtriva and Reyataz.

These were just approved in the U.S...and are being considered for Canada.

There's a lot of interest in these drugs because they will help simplify treatment...they're each given just ONCE a day.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

which statin is best
Men's Health whether they should take finasteride (Proscar) to PREVENT prostate cancer
Thyroid Disorders potential interaction between Evista (raloxifene) and levothyroxine (Synthroid, Eltroxin, etc)
Osteoporosis drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate)
Cardiology whether Coreg is more effective than metoprolol for heart failure
Cardiology a "polypill" for EVERYONE over 55
Ophthalmology two supplements promoted to slow the progression of macular degeneration
safety of DEET in kids
newest HIV drugs, Emtriva and Reyataz
Nutrition more emphasis on reducing "trans fats" in foods
Natural Medicines Natural products will begin to be regulated more like drugs
about promoting Neurontin for off-label uses
Patients with peanut allergy are hearing that they should keep a bottle of activated charcoal on hand
Women's Health the risk of breast cancer in women taking hormone therapy
Women's Health concerns about the safety of black cohosh